Ready to start on a medically assisted weight loss journey, but not sure where to start? With multiple medications available, it can be hard to decide which path to take.

Two weight loss drugs that have garnered significant attention in recent years are semaglutide and tirzepatide. Both have proven effective in helping individuals achieve substantial weight loss, but how do they compare? Let's delve into the details.

Contents

Understanding the Basics: How Do Tirzepatide and Semaglutide Work?

Before we dive into the specifics, let's get a handle on the fundamental differences between the two. Both semaglutide and tirzepatide belong to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. These medications mimic the actions of the GLP-1 hormone, a naturally occurring substance that signals the pancreas to produce insulin and plays a crucial role in regulating blood sugar levels and appetite.

Semaglutide is a GLP-1 receptor agonist that primarily focuses on regulating blood sugar levels and slowing down food digestion and gastric emptying, meaning how quickly food leaves the stomach. It's been approved by the Food and Drug Administration (FDA) for weight management in adults with obesity or who are overweight and type 2 diabetes. Brand names include Ozempic, Wegovy and Rybelsus.

Tirzepatide, on the other hand, takes a dual approach: it's both a GLP-1 receptor antagonist and a glucose-dependent insulinotropic polypeptide (GIP). This dual action makes it more effective at reducing appetite and increasing feelings of fullness. It's marketed under the brand names Mounjaro and Zepbound.

FDA-Approved and Off-Label Uses

Semaglutide was approved in 2017 to treat type 2 diabetes under the brand name Ozempic. Later, as Wegovy, it was approved for body weight management in adults with obesity (a BMI of 30 or higher) or who are overweight (25-30 BMI) with at least one weight-related medical condition, such as high blood pressure.

Tirzepatide was approved to treat type 2 diabetes under the brand name Mounjaro in 2022. It was subsequently approved for chronic weight management in adults with obesity or who are overweight and at least one weight-related condition under the brand name Zepbound.

While these are the FDA-approved indications, healthcare providers may prescribe medications "off-label." This means using a medication for a purpose other than its official FDA approval. In the case of semaglutide and tirzepatide, off-label use for weight loss became increasingly common due to their impressive results in clinical trials, leading to their eventual official approval as weight loss drugs.

Dosage and Administration

Both semaglutide and tirzepatide are administered through weekly subcutaneous injections, meaning they are injected under the skin, typically in the abdomen, thigh or upper arm. Depending on your preference, you may choose to administer the injections at home or have them performed in-office.

Rybelsus, one brand name form of semaglutide, is currently available as a once-daily pill. However, it's primarily prescribed for diabetes management, not weight loss.

How Quickly Do Semaglutide and Tirzepatide Work?

One of the most common questions people have about weight loss medications is how quickly they start working. While both semaglutide and tirzepatide can help you start losing weight relatively soon, the timeline can vary from person to person.

Generally, you may begin to notice a decrease in appetite and changes in your eating habits within the first few weeks of starting either medication. However, it typically takes several weeks to see significant weight loss results..

Weight Loss Results

Clinical trials have consistently demonstrated that tirzepatide leads to significantly greater weight loss compared to semaglutide. This is largely attributed to its dual action on GLP-1 and glucagon receptors, which allows for more robust appetite suppression and weight reduction. However, it's essential to remember that individual results can vary based on factors such as starting weight, adherence to lifestyle changes and overall health.

While tirzepatide has shown more promising weight loss results, semaglutide remains an effective option for many individuals. It has a well-established safety profile, has been proven to help people lose weight and improve blood sugar control and is generally less expensive.

Side Effects: Weighing the Pros and Cons

Although considered safe and well-tolerated, both semaglutide and tirzepatide can cause side effects, especially at higher doses, although they are generally mild and manageable. Common side effects include:

Nausea
Vomiting
Diarrhea
Constipation
Abdominal pain
Decreased appetite

Side effects tend to subside over time as your body adjusts to the medication.

One key difference between the two medications lies in the risk of hypoglycemia (low blood sugar). Due to its impact on both GLP-1 and glucagon receptors, tirzepatide carries a higher risk of hypoglycemia compared to semaglutide.

Potential Serious Side Effects

While the majority of side effects associated with semaglutide and tirzepatide are mild, it's essential to be aware of the more serious potential risks.

Pancreatitis: Both medications have been linked to an increased risk of pancreatitis, an inflammation of the pancreas. Symptoms of pancreatitis include severe abdominal pain, nausea, vomiting and rapid heart rate. If you experience these symptoms, seek medical attention immediately.
Thyroid C-cell tumors: There have been rare reports of thyroid C-cell tumors in patients taking GLP-1 receptor agonists, including semaglutide and tirzepatide. Regular monitoring is essential to detect any potential issues early on.
Gallbladder problems: Some patients may experience gallbladder problems, such as gallstones or inflammation. Symptoms may include abdominal pain, nausea and vomiting.

While these side effects occur infrequently, it's wise to be informed and to seek medical attention promptly if you experience any concerning symptoms.

Contraindications: Who Shouldn’t Take Semaglutide or Tirzepatide?

While semaglutide and tirzepatide have shown impressive results for many people, they are not suitable for everyone. Certain medical conditions can preclude their use, so it's crucial to have a thorough medical evaluation before starting either medication.

Common contraindications for both semaglutide and tirzepatide include:

A history of severe allergic reactions to these medications or any of their ingredients
A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Diabetic ketoacidosis

Tirzepatide has a few additional contraindications, including:

Severe kidney disease
Pancreatitis

Provide your healthcare provider with a complete medical history, including any existing health conditions or medications you're taking. They can determine if either medication is safe for you.

Pregnancy and Breastfeeding: A Cautionary Note

Neither semaglutide nor tirzepatide should be used during pregnancy or while breastfeeding. These medications are designed for weight management and diabetes treatment in adults, and their safety during pregnancy and lactation has not been established. There is a potential risk of harm to both the mother and the baby.

If you are pregnant, breastfeeding, or planning to become pregnant, discuss your weight management goals with your healthcare provider to explore safe and effective alternatives. Always prioritize the health and well-being of both yourself and your baby!

Long-Term Safety: What We Know So Far

While both semaglutide and tirzepatide have shown promising short-term results, long-term safety data is still being collected. These medications are relatively new, and ongoing research is essential to fully assess their potential long-term effects.

Current studies suggest that both medications have a favorable safety profile in the short term. However, long-term use may reveal potential risks or side effects that have not yet been identified.

Monitor for any changes in your health while taking these medications and report any concerns to your healthcare provider. Regular check-ups and follow-ups will help ensure best results.

As research continues to evolve, we will gain a clearer understanding of the long-term implications of semaglutide and tirzepatide.

What Happens When You Stop Taking Semaglutide or Tirzepatide?

Weight loss medications are tools to support your weight management journey, not a quick fix. When you stop taking semaglutide or tirzepatide, your body will gradually return to its previous state if you don't maintain healthy eating habits and regular physical activity.

To sustain your weight loss success, focus on building long-term, healthy lifestyle changes. These medications are most effective as part of a comprehensive weight management program that includes nutrition counseling, exercise guidance and behavioral therapy to help you develop the tools and support needed for lasting results.

Choosing the Right Medication for You

Selecting the right medication for your weight loss journey is a decision that should be made in close collaboration with your healthcare provider. Several factors will influence the best choice for you, including:

Weight loss goals: If your primary objective is maximum weight loss, tirzepatide may be a suitable option. However, if you prioritize blood sugar control and have a lower risk tolerance for hypoglycemia, semaglutide might be a better choice.
Medical history: Individuals with a history of hypoglycemia or certain gastrointestinal conditions may be more inclined towards semaglutide.
Side effect tolerance: Consider your ability to manage potential side effects when making your decision.
Insurance coverage: The cost of the medication and your insurance coverage should also be factored into your choice.

Disclaimer: This blog post is for informational purposes only and does not constitute medical advice. Always consult with a healthcare provider before starting any new medication.